Universal Access and Affordable Medicines
About our work on access to medicines
EPHA joins calls for Treatment Optimization to become a standard step in the development of new medicines in the EU, putting patients at the heart of new developments in research and innovationread more
Analysis & Opinion
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EUread more
Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer asks how can we ensure the needs of patients remain central as new treatments are developed?read more
Time for a new deal14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Putting health first3 June 2019
Trailblazers, routes to better and affordable medicines by 202520 November 2018
How good are our medicines?3 October 2018
Game changers for better and affordable medicines in Europe21 November 2017
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
+32 2 233 3886